GlassScriptPhysician profile
Terri L Mcendree
NPI 1932165099
$2,484.57
in general payments reported to CMS, 2019-2025
37 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $121 · 2021: $245 · 2022: $254 · 2023: $600 · 2024: $633 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,467.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $277.56 | 2019-2023 | |
| Organon LLC | $263.81 | 2022-2025 | Jada System, Nexplanon |
| Myriad Women'S Health, INC. | $263.49 | 2023 | Myrisk |
| Stryker Corporation | $245.00 | 2021 | |
| Exeltis, USA INC. | $145.46 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $136.31 | 2024 | Injectafer |
| Sage Therapeutics, LLC | $123.73 | 2022-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $105.90 | 2023-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Pfizer INC. | $100.05 | 2022-2024 | |
| Therapeuticsmd, INC. | $82.26 | 2019-2022 | |
| Smith+Nephew, INC. | $82.16 | 2019-2024 | Grafix Pl, Renasys Touch, Pico |
| Becton, Dickinson and Company | $58.82 | 2022 | |
| Coopersurgical, INC. | $58.58 | 2019-2024 | Paragard T 380a |
| Millicent US INC | $50.29 | 2019-2020 | |
| Shield Therapeutics INC | $40.67 | 2024-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $40.52 | 2023-2024 | Myfembree |
| Stability Biologics, LLC | $32.48 | 2019 | |
| Covidien LP | $29.68 | 2019 | |
| Mimedx Group, INC. | $29.53 | 2025 | |
| Ethicon US, LLC | $28.50 | 2023 | Ethicon, Vistaseal, Surgiflo Hemostatic Matrix |
| Astellas Pharma US INC | $26.85 | 2023 | Myrbetriq |
| Heron Therapeutics, INC. | $25.84 | 2022 | |
| Tempus Ai, INC | $24.51 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.85 | 2023 | |
| Meditrina | $18.97 | 2024 | |
| Optumhealth Care Solutions, LLC | $16.59 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $16.29 | 2024 | Exparel |
| Dysis Medical, INC. | $15.46 | 2019 | |
| Amgen INC. | $15.35 | 2020 | |
| Ascend Therapeutics US, LLC | $14.92 | 2023 | |
| Agile Therapeutics, INC. | $14.59 | 2023 | Twirla |
| Baxter Healthcare | $14.55 | 2020 | |
| Minerva Surgical, INC | $14.52 | 2024 | |
| Gynesonics, INC. | $14.17 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amag Pharmaceuticals, INC. | $13.17 | 2019 | |
| Mayne Pharma Commercial LLC | $12.11 | 2023 | |
| Avion Pharmaceuticals | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Mcendree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.